UNITED THERAPEUTICS CORPORATION

NASDAQ: UTHR (United Therapeutics Corporation)

Kemas kini terakhir: 21 Apr, 5:52PM

573.46

0.02 (0.00%)

  • 1H 0.00%
  • 5H 1.11%
  • 1B 2.47%
  • 6B 31.13%
  • Tahun Ke Tarikh 15.45%
  • 1T 91.99%
  • 5T 193.53%
Penutupan Terdahulu 573.44
Buka 573.26
Jumlah Dagangan 319,030
Purata Dagangan (3B) 521,627
Modal Pasaran 25,133,426,688
Harga / Pendapatan (P/E TTM) 20.58
Harga / Pendapatan (P/E Ke hadapan) 20.24
Harga / Jualan (P/S) 8.58
Harga / Buku (P/B) 3.41
Julat 52 Minggu
272.12 (-52%) — 607.89 (6%)
Tarikh Pendapatan 29 Apr 2026
Margin Keuntungan 40.44%
Margin Operasi (TTM) 48.19%
EPS Cair (TTM) 25.11
Pertumbuhan Hasil Suku Tahunan (YOY) 17.20%
Pertumbuhan Pendapatan Suku Tahunan (YOY) 5.10%
Jumlah Hutang/Ekuiti (D/E MRQ) 2.94%
Nisbah Semasa (MRQ) 5.46
Aliran Tunai Operasi (OCF TTM) 1.41 B
Aliran Tunai Bebas Leveraj (LFCF TTM) 825.79 M
Pulangan Atas Aset (ROA TTM) 12.93%
Pulangan Atas Ekuiti (ROE TTM) 19.94%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Drug Manufacturers - Specialty & Generic (US) Bercampur Menaik
Drug Manufacturers - Specialty & Generic (Global) Bercampur Menaik
Stok United Therapeutics Corporation Menaik Menaik

AISkor Stockmoo

-0.2
Konsensus Penganalisis 1.5
Aktiviti Orang Dalam -5.0
Volatiliti Harga -0.5
Purata Bergerak Teknikal 2.5
Osilator Teknikal 0.5
Purata -0.20

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
UTHR 25 B - 20.58 3.41
NBIX 13 B - 27.94 4.04
HCM 2 B - 5.13 1.94
VTRS 17 B 3.21% - 1.17
KNSA 4 B - 60.74 6.31
BCRX 2 B - 7.85 -

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.
Sektor Healthcare
Industri Drug Manufacturers - Specialty & Generic
Gaya Pelaburan Mid Core
% Dimiliki oleh Orang Dalam 1.75%
% Dimiliki oleh Institusi 100.69%
Julat 52 Minggu
272.12 (-52%) — 607.89 (6%)
Julat Harga Sasaran
466.00 (-18%) — 705.00 (22%)
Tinggi 705.00 (UBS, 22.94%) Beli
Median 600.00 (4.63%)
Rendah 466.00 (Wells Fargo, -18.74%) Pegang
Purata 602.00 (4.98%)
Jumlah 6 Beli, 1 Pegang
Harga Purata @ Panggilan 505.13
Syarikat Tarikh Harga Sasaran Panggilan Harga @ Panggilan
Cantor Fitzgerald 12 Mar 2026 625.00 (8.99%) Beli 532.82
UBS 05 Mar 2026 705.00 (22.94%) Beli 485.06
HC Wainwright & Co. 26 Feb 2026 600.00 (4.63%) Beli 503.60
Oppenheimer 26 Feb 2026 600.00 (4.63%) Beli 503.60
RBC Capital 26 Feb 2026 643.00 (12.13%) Beli 503.60
TD Cowen 26 Feb 2026 575.00 (0.27%) Beli 503.60
Wells Fargo 26 Feb 2026 466.00 (-18.74%) Pegang 503.60
Nama Purata Belian ($) Purata Jualan ($) Jumlah Net Jumlah Nilai Bersih ($)
EDGEMOND JAMES - 571.78 -40,000 -22,846,824
PATUSKY CHRISTOPHER - 567.16 -2,910 -1,650,436
ROTHBLATT MARTINE A - 571.08 -85,500 -48,827,340
Jumlah Keseluruhan Kuantiti Bersih -128,410
Jumlah Keseluruhan Nilai Bersih ($) -73,324,600
Purata Pembelian Keseluruhan ($) -
Purata Jualan Keseluruhan ($) 571.05
Nama Pemegang Tarikh Jenis Kuantiti Harga Nilai ($)
EDGEMOND JAMES Pegawai 30 Apr 2026 Jual automatik (-) 10,000 571.35 5,713,500
EDGEMOND JAMES Pegawai 30 Apr 2026 Pelaksanaan pilihan 10,000 - -
ROTHBLATT MARTINE A Pegawai 30 Apr 2026 Jual automatik (-) 9,500 571.35 5,427,825
ROTHBLATT MARTINE A Pegawai 30 Apr 2026 Pelaksanaan pilihan 9,500 - -
ROTHBLATT MARTINE A Pegawai 29 Apr 2026 Jual automatik (-) 9,500 571.07 5,425,165
ROTHBLATT MARTINE A Pegawai 29 Apr 2026 Pelaksanaan pilihan 9,500 - -
ROTHBLATT MARTINE A Pegawai 28 Apr 2026 Jual automatik (-) 9,500 569.11 5,406,545
ROTHBLATT MARTINE A Pegawai 28 Apr 2026 Pelaksanaan pilihan 9,500 - -
EDGEMOND JAMES Pegawai 27 Apr 2026 Jual automatik (-) 10,000 566.99 5,669,900
EDGEMOND JAMES Pegawai 27 Apr 2026 Pelaksanaan pilihan 10,000 - -
ROTHBLATT MARTINE A Pegawai 27 Apr 2026 Jual automatik (-) 9,500 566.99 5,386,405
ROTHBLATT MARTINE A Pegawai 27 Apr 2026 Pelaksanaan pilihan 9,500 - -
PATUSKY CHRISTOPHER Pengarah 24 Apr 2026 Jual automatik (-) 2,910 567.16 1,650,436
PATUSKY CHRISTOPHER Pengarah 24 Apr 2026 Pelaksanaan pilihan 2,910 - -
ROTHBLATT MARTINE A Pegawai 24 Apr 2026 Jual automatik (-) 9,500 567.16 5,388,020
ROTHBLATT MARTINE A Pegawai 24 Apr 2026 Pelaksanaan pilihan 9,500 - -
ROTHBLATT MARTINE A Pegawai 23 Apr 2026 Jual automatik (-) 9,500 572.85 5,442,075
ROTHBLATT MARTINE A Pegawai 23 Apr 2026 Pelaksanaan pilihan 9,500 - -
EDGEMOND JAMES Pegawai 23 Apr 2026 Jual automatik (-) 9,636 572.85 5,519,983
EDGEMOND JAMES Pegawai 23 Apr 2026 Pelaksanaan pilihan 10,000 - -
ROTHBLATT MARTINE A Pegawai 22 Apr 2026 Jual automatik (-) 9,500 574.29 5,455,755
ROTHBLATT MARTINE A Pegawai 22 Apr 2026 Pelaksanaan pilihan 9,500 - -
EDGEMOND JAMES Pegawai 22 Apr 2026 Jual automatik (-) 364 574.29 209,042
ROTHBLATT MARTINE A Pegawai 21 Apr 2026 Jual automatik (-) 9,500 573.46 5,447,870
ROTHBLATT MARTINE A Pegawai 21 Apr 2026 Pelaksanaan pilihan 9,500 - -
EDGEMOND JAMES Pegawai 20 Apr 2026 Jual automatik (-) 10,000 573.44 5,734,400
EDGEMOND JAMES Pegawai 20 Apr 2026 Pelaksanaan pilihan 10,000 - -
ROTHBLATT MARTINE A Pegawai 20 Apr 2026 Jual automatik (-) 9,500 573.44 5,447,680
ROTHBLATT MARTINE A Pegawai 20 Apr 2026 Pelaksanaan pilihan 9,500 - -
Papar semua

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2026 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda